Ariad Pharmaceuticals Inc
ARIA
ARIA was delisted on the 15th of February, 2017.
166 hedge funds and large institutions have $801M invested in Ariad Pharmaceuticals Inc in 2013 Q4 according to their latest regulatory filings, with 46 funds opening new positions, 51 increasing their positions, 58 reducing their positions, and 88 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 2 → 4 (+2)
12% less repeat investments, than reductions
Existing positions increased: 51 | Existing positions reduced: 58
20% less funds holding
Funds holding: 208 → 166 (-42)
26% less call options, than puts
Call options by funds: $35.5M | Put options by funds: $48.1M
48% less first-time investments, than exits
New positions opened: 46 | Existing positions closed: 88
72% less capital invested
Capital invested by funds: $2.85B → $801M (-$2.05B)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$28.3M |
| 2 |
PAI
Palo Alto Investors
Palo Alto,
California
|
+$18.6M |
| 3 |
State Street
Boston,
Massachusetts
|
+$14.9M |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$13.1M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$12M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
-$106M |
| 2 |
Neuberger Berman Group
New York
|
-$100M |
| 3 |
CWAM
Columbia Wanger Asset Management
Chicago,
Illinois
|
-$97.4M |
| 4 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$84.8M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$63.8M |
ARIA Hedge Fund Activity: Q4 2013 in Review
166 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Ariad Pharmaceuticals Inc (ARIA) for Q4 2013, worth a combined $801M — down 72% from $2.85B a quarter earlier.
Sellers outnumbered buyers: 88 funds closed out of ARIA and 46 opened new positions — a net loss of 42 holders — while 58 trimmed existing stakes and 51 added.
The largest buyer was Camber Capital Management, opening a new position worth an estimated $28.3M. The largest seller was Waddell & Reed Financial, exiting entirely with an estimated $106M sold.
- 166 institutional investors held Ariad Pharmaceuticals Inc (ARIA) as of Q4 2013, down from 208 in Q3 2013.
- Funds reported $801M of Ariad Pharmaceuticals Inc stock for Q4 2013, down 72% quarter-over-quarter.
- 46 funds opened new Ariad Pharmaceuticals Inc positions in Q4 2013 and 88 closed out, a net change of -42 holders.
- The largest Ariad Pharmaceuticals Inc buyer in Q4 2013 was Camber Capital Management, an estimated $28.3M added.
- The largest Ariad Pharmaceuticals Inc seller in Q4 2013 was Waddell & Reed Financial, an estimated $106M sold.
Based on aggregated 13F filings for Q4 2013.